Proton Collaborative Group: Clinical Trials

4 trials sponsored by Proton Collaborative Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Active not recruiting 1, Terminated 1
Phase 21Terminated 1

Follow Proton Collaborative Group: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Proton Therapy - Breast Cancer
Phase 3RecruitingProton Collaborative Group2762024-03-212026-09-29
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer
Luteinizing hormone-releasing hormone (LHRH), Docetaxel, Conformal Radiation Therapy (RT) - Prostate Cancer
Phase 2 / Phase 3TerminatedProton Collaborative Group22012-07-012016-03-14
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Radiation, Androgen Suppression Therapy - Prostate Cancer
Phase 3RecruitingProton Collaborative Group1922012-01-012026-09-29
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer
Proton Radiation Hypofractionation, Proton Radiation Standard Fractionation - Prostate Cancer
Phase 3Active not recruitingProton Collaborative Group1502010-11-012026-09-29

Conditions studied

Prostatic Neoplasms (3)  ·  Breast Neoplasms (1)  ·  Neoplasms (1)

Interventions

Goserelin (2)  ·  Leuprolide (2)  ·  Proton Therapy (2)  ·  Buserelin (1)  ·  Docetaxel (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Radiation (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Triptorelin Pamoate (1)  ·  luprolide acetate gel depot (1)

Countries

United States (4)

Top investigators

Carlos Vargas, MD (3)  ·  Isabelle Choi, MD (1)

Results publications

PMID 24423462, PMID 38972465